i3 Consult is pleased to announce the return of its highly popular ‘Quote of the Week’ feature — a series designed to inspire, educate, and provoke thoughtful reflection among professionals in the healthcare and life...
In a rapidly evolving life sciences landscape, precision is not just a principle — it’s a competitive advantage. i3 Consult, a specialist consultancy in life sciences strategy and innovation, is reinforcing its commitment to focus...
Introduction In an era of shrinking margins and rising R&D expenses, cost optimization is no longer optional for life science companies. By harnessing AI-powered analytics, businesses can pinpoint inefficiencies, reduce operational waste, and maximize return...
As the life sciences industry continues to evolve, companies are increasingly turning to value chain analysis (VCA) to drive profitability and enhance competitive advantage. This strategic tool enables life science companies to systematically assess each...
The life cycle of a drug, from its discovery to market approval and eventual discontinuation, varies significantly depending on the therapeutic class of the drug. Different therapeutic classes, such as antibiotics, oncology drugs, cardiovascular agents,...
i3 Consult uses AI in various ways to solve problems for life science clients. AI technologies can help our clients gather insights, analyze data, and make more informed decisions. Here are some we ways we...
Atorvastatin is a statin medication used to lower cholesterol levels in the blood. It was originally developed by Pfizer and is commonly sold under the brand name Lipitor. Here is a brief overview of its...
In the last of our series of posts on our service offering, i3 Consult from day one of business has also been offering cost reduction analysis as one of its core services to our clients...
i3 Consult from day one of business has been offering value chain analysis as one of its core services to our clients in the life sciences and here are highlighted some of the key reasons...
Executive management of life science companies with their product candidates going through exploratory research or undergoing clinical development bear the mantra “how can we get better drugs to the market faster?” Despite the explosion of...